Disruption of β-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice
- 31 May 2004
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 126 (5), 1374-1386
- https://doi.org/10.1053/j.gastro.2004.02.014
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Recurrent allelic deletions at mouse chromosomes 4 and 14 in Myc-induced liver tumorsOncogene, 2002
- Integration of a c-myc Transgene Results in Disruption of the Mouse Gtf2ird1 Gene, the Homologue of the Human GTF2IRD1 Gene Hemizygously Deleted in Williams–Beuren SyndromeGenomics, 2001
- Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesisOncogene, 2000
- The Hallmarks of CancerCell, 2000
- β‐Catenin (Ctnnb1) Gene Mutations in Diethylnitrosamine (DEN)‐induced Liver Tumors in Male F344 RatsJapanese Journal of Cancer Research, 1999
- A recurring pattern of chromosomal aberrations in mammary gland tumors of MMTV-cmyc transgenic miceGenes, Chromosomes and Cancer, 1999
- Disruption of Redox Homeostasis in the Transforming Growth Factor-α/c-myc Transgenic Mouse Model of Accelerated HepatocarcinogenesisJournal of Biological Chemistry, 1998
- Interspecies comparison of liver carcinogenesis: implications for cancer risk assessmentCarcinogenesis: Integrative Cancer Research, 1997
- A comprehensive genetic map of the mouse genomeNature, 1996
- Hepatocellular carcinomaDigestive Diseases and Sciences, 1991